Cabaletta Bio Inc reports results for the quarter ended in March - Earnings Summary

Cabaletta Bio

11/05/2023 13:43

* Cabaletta Bio Inc  CABA.OQ  reported a quarterly adjusted
loss
of 45 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 48
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Cabaletta Bio Inc's reported EPS for the quarter was a
loss
of 45 cents​.
    * The mean earnings estimate of analysts had fallen by
about 11.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cabaletta Bio Inc shares had risen by 48.7% this
quarter and
gained 33.0% so far this year.
    * The company reported a quarterly loss of $15.85 million.
    * Wall Street's median 12-month price target for Cabaletta
Bio Inc
is $14.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 12:43 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.48          -0.45          Beat
 Dec. 31 2022      -0.45          -0.52          Missed
 Sep. 30 2022      -0.48          -0.39          Beat
 Jun. 30 2022      -0.50          -0.45          Beat